Skip to main content
Log in

A possible role of classical complement pathway activation in the pathogenesis of immunoglobulin G nephropathy: a case report

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Immunoglobulin G (IgG) nephropathy refers to a rare group of diseases characterized by deposits of IgG in the mesangial region. However, IgG nephropathy is controversial as a single disease entity, and its pathogenesis remains to be elucidated. In the present report, we discuss a case of IgG nephropathy in which we observed activation of the classical complement pathway.

A 47-year-old woman was admitted to our hospital with nephrotic syndrome. Light-microscopic examination revealed neither proliferative nor sclerotic lesions in the glomeruli. However, unusual and large deposits were observed in the paramesangial area. An immunofluorescence study revealed predominant IgG and C1q and slight C3 deposits in the paramesangial area, suggesting immune-complex-type glomerular disease. An electron microscopic study also revealed different sizes of non-organized electron-dense deposits with a similar pattern of distribution, which were accompanied by foot process effacement. Clinically, there was no evidence of systemic diseases, such as infectious or autoimmune diseases (including systemic lupus erythematosus). Based on these findings, she was diagnosed with IgG nephropathy and treated with prednisolone. Steroid therapy was effective, and complete remission was maintained.

Additional immunological examination revealed that IgG deposits were polyclonal and consisted mainly of the IgG1 and IgG3 subclasses. Furthermore, staining was positive for C4d and C5b-9. The present findings indicate that the pathogenesis of IgG nephropathy in our patient may have involved activation of the classical complement pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Sato M, Kojima H, Nabeshima K, Nakajima Y, Koshikawa S. Primary glomerulonephritis with predominant mesangial immunoglobulin G deposits–a distinct entity? Nephron. 1993;64:122–8.

    Article  CAS  Google Scholar 

  2. Yoshikawa N, Iijima K, Shimomura M, Nakamura H, Ito H. IgG-associated primary glomerulonephritis in children. Clin Nephrol. 1994;42:281–7.

    CAS  Google Scholar 

  3. Kano K, Ueda Y, Iidaka K, Ichimura T. Glomerulonephritis with predominant paramesangial IgG deposition. Pathol Int. 1996;46:306–9.

    Article  CAS  Google Scholar 

  4. Fakhouri F, Darré S, Droz D, Lemaire M, Nabarra B, Machet MC, Chauveau D, Lesavre P, Grünfeld JP, Noël LH, Knebelmann B. Mesangial IgG glomerulonephritis: a distinct type of primary glomerulonephritis. J Am Soc Nephrol. 2002;13:379–87.

    Article  Google Scholar 

  5. Jourde-Chiche N, Moal V, Daniel L, Purgus R, Legis T Jr, Vacher-Coponat H, Moussi-Frances J, Berland Y. Early IgG glomerulonephritis recurrence in a kidney transplant recipient. Clin Nephrol. 2008;70:340–3.

    Article  CAS  Google Scholar 

  6. Huerta A, Bomback AS, Liakopoulos V, Palanisamy A, Stokes MB, D’Agati VD, Radhakrishnan J, Markowitz GS, Appel GB. Renal-limited “lupus-like” nephritis. Nephrol Dial Transplant. 2012;27:2337–42.

    Article  CAS  Google Scholar 

  7. Lim BJ, Hong SW, Jeong HJ. IgG nephropathy - confusion and overlap with C1q nephropathy. Clin Nephrol. 2009;72:360–5.

    Article  CAS  Google Scholar 

  8. Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis. 1985;6:103–10.

    Article  CAS  Google Scholar 

  9. Mii A, Shimizu A, Masuda Y, Fujita E, Aki K, Ishizaki M, Sato S, Griesemer A, Fukuda Y. Current status and issues of C1q nephropathy. Clin Exp Nephrol. 2009;13:263–74.

    Article  CAS  Google Scholar 

  10. Lau KK, Gaber LW, Delos Santos NM, Wyatt RJ. C1q nephropathy: features at presentation and outcome. Pediatr Nephrol. 2005;20:744–9.

    Article  Google Scholar 

  11. Fukuma Y, Hisano S, Segawa Y, Niimi K, Tsuru N, Kaku Y, Hatae K, Kiyoshi Y, Mitsudome A, Iwasaki H. Clinicopathologic correlation of C1q nephropathy in children. Am J Kidney Dis. 2006;47:412–8.

    Article  Google Scholar 

  12. Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D’Agati VD. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int. 2003;64:1232–40.

    Article  CAS  Google Scholar 

  13. Hisano S, Fukuma Y, Segawa Y, Niimi K, Kaku Y, Hatae K, Saitoh T, Takeshita M, Iwasaki H. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol. 2008;3:1637–43.

    Article  Google Scholar 

  14. Onitsuka S, Tanabe K, Toma H, Yamaguchi Y. Mesangial proliferative glomerulonephritis with predominant mesangial IgG deposition in renal allograft. Nephron. 2000;86:404–6.

    Article  CAS  Google Scholar 

  15. Jalalah SM. IgG glomerulonephritis: a morphologic study of a rare entity. Saudi J Kidney Dis Transpl. 2009;20:798–801.

    Google Scholar 

  16. Iskandar SS, Browning MC, Lorentz WB. C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis. 1991;18:459–65.

    Article  CAS  Google Scholar 

  17. Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: C1q nephropathy. Am J Kidney Dis. 2015;66:e13-4.

    Article  Google Scholar 

  18. van de Lest NA, Zandbergen M, Wolterbeek R, Kreutz R, Trouw LA, Dorresteijn EM, Bruijn JA, Bajema IM, Scharpfenecker M, Chua JS. Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis. Kidney Int. 2019;96:738–49.

    Article  Google Scholar 

  19. Drachenberg CB, Papadimitriou JC, Chandra P, Haririan A, Mendley S, Weir MR, Rubin MF. Epidemiology and pathophysiology of glomerular C4d staining in native kidney biopsies. Kidney Int Rep. 2019;4:1555–67.

    Article  Google Scholar 

  20. Cooper NR. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol. 1985;37:151–216.

    Article  CAS  Google Scholar 

  21. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.

    Article  Google Scholar 

  22. Pickering WP, Bailey RR, Gardner J. IgG nephropathy: an uncommon form of primary glomerulonephritis? N Z Med J. 1996;109:365.

    CAS  Google Scholar 

  23. Sepandj F, McFarlane C, Trillo A. Nephrotic syndrome secondary to primary immunoglobulin-G mesangioproliferative glomerulonephritis. Nephrol Dial Transplant. 1998;13:1889–90.

    Article  CAS  Google Scholar 

  24. Assadi FK. IgG-associated mesangial glomerulonephritis in a patient with Down syndrome. Med Sci Monit. 2004;10:CS54-6.

    Google Scholar 

  25. Kharroubi M, Ben Fatma L, Rais L, Jebali H, Mami I, Zouaghi MK. Primary glomerulonephritis with predominant mesangial Immunoglobulin G deposits. Tunis Med. 2018;96:442–4.

    Google Scholar 

Download references

Acknowledgements

We thank Ms. Arimi Ishikawa and Ms. Asae Kurosawa for their technical assistance.

Funding

No funding to declare.

Author information

Authors and Affiliations

Authors

Contributions

MA, HA, TK, AM, and YS treated the patient and evaluated the clinical images. AM and AS were responsible for the pathological diagnosis. MA, AM, and TK contributed to clinical data acquisition. MA, AM, and AS interpreted the data and prepared the manuscript. All authors read and approved the final version of this manuscript.

Corresponding author

Correspondence to Akiko Mii.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

Ethical approval

No experimental study was conducted. All procedures performed in this case were in accordance with the ethical standards of the institutional committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards.

Consent for publication

Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. This work does not contain any studies with animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arai, M., Mii, A., Hirama, A. et al. A possible role of classical complement pathway activation in the pathogenesis of immunoglobulin G nephropathy: a case report. CEN Case Rep 12, 14–22 (2023). https://doi.org/10.1007/s13730-022-00710-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-022-00710-5

Keywords

Navigation